Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017

December 2017 | 116 pages | ID: GEFB42EA42AEN
QYResearch

Abstracts

This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• GSK
• Eli Lilly
• Sumitomo Dainippon Pharma
• Intarcia Therapeutics
• Servier
• Jiangsu Hansoh Pharmaceutical
• Novo Nordisk
• Emisphere
• Uni-Bio Science Group
• Takeda
• 3SBio
• Merck
• Dong-A Pharmaceutical
• Luye Pharma Group
• Eurofarma
• Geropharm
• Alkem Labs
• SatRx
• Pfizer
• Jiangsu Hengrui Medicine

By types, the market can be split into

• Alpha-glucosidase Inhibitors
• Amylin Agonists
• Biguanides
• Dipeptidyl Peptidase-4 (DPP4) Inhibitors
• Glinides / Meglitinides
• GLP-1 Analogs / GLP-1 Agonists
• Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
• Sulfonylureas
• Thiazolidinediones
• Others

By Application, the market can be split into

• Hospital Pharmacy
• Retail Pharmacies
• Online Pharmacy
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Non-Insulin Therapies for Diabetes Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NON-INSULIN THERAPIES FOR DIABETES

1.1 Definition and Specifications of Non-Insulin Therapies for Diabetes
  1.1.1 Definition of Non-Insulin Therapies for Diabetes
  1.1.2 Specifications of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes
  1.2.1 Alpha-glucosidase Inhibitors
  1.2.2 Amylin Agonists
  1.2.3 Biguanides
  1.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
  1.2.5 Glinides / Meglitinides
  1.2.6 GLP-1 Analogs / GLP-1 Agonists
  1.2.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
  1.2.8 Sulfonylureas
  1.2.9 Thiazolidinediones
  1.2.10 Others
1.3 Applications of Non-Insulin Therapies for Diabetes
  1.3.1 Hospital Pharmacy
  1.3.2 Retail Pharmacies
  1.3.3 Online Pharmacy
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NON-INSULIN THERAPIES FOR DIABETES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes
2.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
2.4 Industry Chain Structure of Non-Insulin Therapies for Diabetes

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NON-INSULIN THERAPIES FOR DIABETES

3.1 Capacity and Commercial Production Date of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016

4 GLOBAL NON-INSULIN THERAPIES FOR DIABETES OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Non-Insulin Therapies for Diabetes Capacity and Growth Rate Analysis
  4.2.2 2016 Non-Insulin Therapies for Diabetes Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales and Growth Rate Analysis
  4.3.2 2016 Non-Insulin Therapies for Diabetes Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Non-Insulin Therapies for Diabetes Sales Price
  4.4.2 2016 Non-Insulin Therapies for Diabetes Sales Price Analysis (Company Segment)

5 NON-INSULIN THERAPIES FOR DIABETES REGIONAL MARKET ANALYSIS

5.1 North America Non-Insulin Therapies for Diabetes Market Analysis
  5.1.1 North America Non-Insulin Therapies for Diabetes Market Overview
  5.1.2 North America 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.1.4 North America 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.2 China Non-Insulin Therapies for Diabetes Market Analysis
  5.2.1 China Non-Insulin Therapies for Diabetes Market Overview
  5.2.2 China 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.2.4 China 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.3 Europe Non-Insulin Therapies for Diabetes Market Analysis
  5.3.1 Europe Non-Insulin Therapies for Diabetes Market Overview
  5.3.2 Europe 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.3.4 Europe 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.4 Southeast Asia Non-Insulin Therapies for Diabetes Market Analysis
  5.4.1 Southeast Asia Non-Insulin Therapies for Diabetes Market Overview
  5.4.2 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.4.4 Southeast Asia 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.5 Japan Non-Insulin Therapies for Diabetes Market Analysis
  5.5.1 Japan Non-Insulin Therapies for Diabetes Market Overview
  5.5.2 Japan 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.5.4 Japan 2016 Non-Insulin Therapies for Diabetes Market Share Analysis
5.6 India Non-Insulin Therapies for Diabetes Market Analysis
  5.6.1 India Non-Insulin Therapies for Diabetes Market Overview
  5.6.2 India 2012-2017E Non-Insulin Therapies for Diabetes Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Non-Insulin Therapies for Diabetes Sales Price Analysis
  5.6.4 India 2016 Non-Insulin Therapies for Diabetes Market Share Analysis

6 GLOBAL 2012-2017E NON-INSULIN THERAPIES FOR DIABETES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Sales by Type
6.2 Different Types of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
6.3 Different Types of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
  6.3.1 Alpha-glucosidase Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.2 Amylin Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.3 Biguanides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.5 Glinides / Meglitinides of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.6 GLP-1 Analogs / GLP-1 Agonists of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.8 Sulfonylureas of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.9 Thiazolidinediones of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  6.3.10 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NON-INSULIN THERAPIES FOR DIABETES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Non-Insulin Therapies for Diabetes Consumption by Application
7.2 Different Application of Non-Insulin Therapies for Diabetes Product Interview Price Analysis
7.3 Different Application of Non-Insulin Therapies for Diabetes Product Driving Factors Analysis
  7.3.1 Hospital Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  7.3.2 Retail Pharmacies of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  7.3.3 Online Pharmacy of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis
  7.3.4 Others of Non-Insulin Therapies for Diabetes Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NON-INSULIN THERAPIES FOR DIABETES

8.1 GSK
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 GSK 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 GSK 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.2 Eli Lilly
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eli Lilly 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.3 Sumitomo Dainippon Pharma
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sumitomo Dainippon Pharma 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.4 Intarcia Therapeutics
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Intarcia Therapeutics 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.5 Servier
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Servier 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Servier 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.6 Jiangsu Hansoh Pharmaceutical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Jiangsu Hansoh Pharmaceutical 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.7 Novo Nordisk
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Novo Nordisk 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.8 Emisphere
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Emisphere 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Emisphere 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.9 Uni-Bio Science Group
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Uni-Bio Science Group 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.10 Takeda
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Takeda 2016 Non-Insulin Therapies for Diabetes Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Takeda 2016 Non-Insulin Therapies for Diabetes Business Region Distribution Analysis
8.11 3SBio
8.12 Merck
8.13 Dong-A Pharmaceutical
8.14 Luye Pharma Group
8.15 Eurofarma
8.16 Geropharm
8.17 Alkem Labs
8.18 SatRx
8.19 Pfizer
8.20 Jiangsu Hengrui Medicine

9 DEVELOPMENT TREND OF ANALYSIS OF NON-INSULIN THERAPIES FOR DIABETES MARKET

9.1 Global Non-Insulin Therapies for Diabetes Market Trend Analysis
  9.1.1 Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Non-Insulin Therapies for Diabetes Sales Price Forecast
9.2 Non-Insulin Therapies for Diabetes Regional Market Trend
  9.2.1 North America 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
  9.2.2 China 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
  9.2.3 Europe 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
  9.2.5 Japan 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
  9.2.6 India 2017-2022 Non-Insulin Therapies for Diabetes Consumption Forecast
9.3 Non-Insulin Therapies for Diabetes Market Trend (Product Type)
9.4 Non-Insulin Therapies for Diabetes Market Trend (Application)

10 NON-INSULIN THERAPIES FOR DIABETES MARKETING TYPE ANALYSIS

10.1 Non-Insulin Therapies for Diabetes Regional Marketing Type Analysis
10.2 Non-Insulin Therapies for Diabetes International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-Insulin Therapies for Diabetes by Region
10.4 Non-Insulin Therapies for Diabetes Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NON-INSULIN THERAPIES FOR DIABETES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NON-INSULIN THERAPIES FOR DIABETES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Insulin Therapies for Diabetes
Table Product Specifications of Non-Insulin Therapies for Diabetes
Table Classification of Non-Insulin Therapies for Diabetes
Figure Global Production Market Share of Non-Insulin Therapies for Diabetes by Type in 2016
Figure Alpha-glucosidase Inhibitors Picture
Table Major Manufacturers of Alpha-glucosidase Inhibitors
Figure Amylin Agonists Picture
Table Major Manufacturers of Amylin Agonists
Figure Biguanides Picture
Table Major Manufacturers of Biguanides
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Picture
Table Major Manufacturers of Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Figure Glinides / Meglitinides Picture
Table Major Manufacturers of Glinides / Meglitinides
Figure GLP-1 Analogs / GLP-1 Agonists Picture
Table Major Manufacturers of GLP-1 Analogs / GLP-1 Agonists
Figure Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Picture
Table Major Manufacturers of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Figure Sulfonylureas Picture
Table Major Manufacturers of Sulfonylureas
Figure Thiazolidinediones Picture
Table Major Manufacturers of Thiazolidinediones
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Non-Insulin Therapies for Diabetes
Figure Global Consumption Volume Market Share of Non-Insulin Therapies for Diabetes by Application in 2016
Figure Hospital Pharmacy Examples
Table Major Consumers of Hospital Pharmacy
Figure Retail Pharmacies Examples
Table Major Consumers of Retail Pharmacies
Figure Online Pharmacy Examples
Table Major Consumers of Online Pharmacy
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of Non-Insulin Therapies for Diabetes by Regions
Figure North America Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure China Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure Japan Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Figure India Non-Insulin Therapies for Diabetes Market Size (Million USD) (2012-2022)
Table Non-Insulin Therapies for Diabetes Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-Insulin Therapies for Diabetes in 2016
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Industry Chain Structure of Non-Insulin Therapies for Diabetes
Table Capacity and Commercial Production Date of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Non-Insulin Therapies for Diabetes 2012-2017
Figure Global 2012-2017E Non-Insulin Therapies for Diabetes Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Non-Insulin Therapies for Diabetes Market Size (Value) and Growth Rate
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Capacity and Growth Rate
Table 2016 Global Non-Insulin Therapies for Diabetes Capacity () List (Company Segment)
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Sales () and Growth Rate
Table 2016 Global Non-Insulin Therapies for Diabetes Sales () List (Company Segment)
Table 2012-2017E Global Non-Insulin Therapies for Diabetes Sales Price ()
Table 2016 Global Non-Insulin Therapies for Diabetes Sales Price () List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure North America 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure North America 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure China 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure China 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Europe 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Europe 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Southeast Asia 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Southeast Asia 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure Japan 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure Japan 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption () of Non-Insulin Therapies for Diabetes 2012-2017E
Figure India 2012-2017E Non-Insulin Therapies for Diabetes Sales Price ()
Figure India 2016 Non-Insulin Therapies for Diabetes Sales Market Share
Table Global 2012-2017E Non-Insulin Therapies for Diabetes Sales () by Type
Table Different Types Non-Insulin Therapies for Diabetes Product Interview Price
Table Global 2012-2017E Non-Insulin Therapies for Diabetes Sales () by Application
Table Different Application Non-Insulin Therapies for Diabetes Product Interview Price
Table GSK Information List
Table Product A Overview
Table Product B Overview
Table 2016 GSK Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 GSK Non-Insulin Therapies for Diabetes Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Eli Lilly Non-Insulin Therapies for Diabetes Business Region Distribution
Table Sumitomo Dainippon Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Business Region Distribution
Table Intarcia Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2016 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Business Region Distribution
Table Servier Information List
Table Product A Overview
Table Product B Overview
Table 2016 Servier Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Servier Non-Insulin Therapies for Diabetes Business Region Distribution
Table Jiangsu Hansoh Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Novo Nordisk Non-Insulin Therapies for Diabetes Business Region Distribution
Table Emisphere Information List
Table Product A Overview
Table Product B Overview
Table 2016 Emisphere Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Emisphere Non-Insulin Therapies for Diabetes Business Region Distribution
Table Uni-Bio Science Group Information List
Table Product A Overview
Table Product B Overview
Table 2016 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Business Region Distribution
Table Takeda Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Non-Insulin Therapies for Diabetes Revenue (Million USD), Sales (), Ex-factory Price ()
Figure 2016 Takeda Non-Insulin Therapies for Diabetes Business Region Distribution
Table 3SBio Information List
Table Merck Information List
Table Dong-A Pharmaceutical Information List
Table Luye Pharma Group Information List
Table Eurofarma Information List
Table Geropharm Information List
Table Alkem Labs Information List
Table SatRx Information List
Table Pfizer Information List
Table Jiangsu Hengrui Medicine Information List
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size () and Growth Rate Forecast
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Non-Insulin Therapies for Diabetes Sales Price () Forecast
Figure North America 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure China 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Europe 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure Japan 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Figure India 2017-2022 Non-Insulin Therapies for Diabetes Consumption Volume () and Growth Rate Forecast
Table Global Sales Volume () of Non-Insulin Therapies for Diabetes by Type 2017-2022
Table Global Consumption Volume () of Non-Insulin Therapies for Diabetes by Application 2017-2022
Table Traders or Distributors with Contact Information of Non-Insulin Therapies for Diabetes by Region